Fund Holdings — Opaleye Management Inc.

Total Portfolio Value:
$887.72M
Total Bought:
$149.38M
Total Sold:
$358.89M
Net Transaction:
-$209.51M
Notable People:
James Aaron Silverman
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Eton Pharmaceuticals, Inc.(ETON)2,860,0002,440,000-420,000$103.53M$125.64M14.15%+$22.10M
Disc Medicine, Inc.(IRON)855,0001,095,000+240,000$62.53M$71.68M8.07%+$9.14M
Harrow, Inc.(HROW)2,400,0002,105,000-295,000$101.93M$64.83M7.30%-$37.09M
Liquidia Corporation(LQDA)2,447,5002,110,000-337,500$195.14M$63.85M7.19%-$131.29M
UroGen Pharma Ltd.(URGN)1,439,9961,439,9960$52.99M$58.51M6.59%+$5.52M
Sol-Gel Technologies LtdSHS NEW
SHS NEW
500,000555,000+55,000$37.07M$41.23M4.64%+$4.16M
MeiraGTx Holdings plc(MGTX)3,550,0003,600,000+50,000$47.96M$39.60M4.46%-$8.36M
TG Therapeutics, Inc.(TGTX)535,000557,000+22,000$29.39M$31.07M3.50%+$1.68M
Alpha Cognition Inc2,895,4673,303,904+408,437$20.91M$29.74M3.35%+$8.83M
Immix Biopharma Inc2,345,0002,825,000+480,000$24.18M$29.39M3.31%+$5.22M
Crescent Biopharma Inc.1,319,3511,645,984+326,633$23.75M$24.01M2.71%+$266.6K
Verastem, Inc.(VSTM)1,800,0002,753,333+953,333$6.88M$22.16M2.50%+$15.29M
Revolution Medicines, Inc.(RVMD)100,000100,0000$18.73M$20.53M2.31%+$1.80M
Replimune Group, Inc.(REPL)1,384,9931,384,9930$15.33M$18.34M2.07%+$3.00M
Stoke Therapeutics, Inc.(STOK)700,000692,181-7,819$22.90M$18.00M2.03%-$4.91M
Summit Therapeutics Inc.(SMMT)01,051,901+1,051,901$0$17.79M2.00%+$17.79M
Rezolute Inc6,300,0004,087,045-2,212,955$32.76M$16.92M1.91%-$15.84M
Biohaven Ltd.(BHVN)77,9151,190,000+1,112,085$1.16M$15.89M1.79%+$14.73M
Protagonist Therapeutics Inc100,000100,0000$12.26M$14.09M1.59%+$1.83M
Monte Rosa Therapeutics Inc745,0001,035,000+290,000$18.03M$12.35M1.39%-$5.68M
Rhythm Pharmaceuticals, Inc.(RYTM)122,500122,5000$13.60M$11.66M1.31%-$1.94M
Q32 Bio Inc931,0001,120,000+189,000$11.86M$9.26M1.04%-$2.60M
Harmony Biosciences Holdings, Inc.(HRMY)0230,000+230,000$0$9.03M1.02%+$9.03M
Editas Medicine Inc3,861,9303,486,452-375,478$12.51M$8.96M1.01%-$3.55M
Alumis Inc550,0001,001,900+451,900$15.48M$7.40M0.83%-$8.07M
Edgewise Therapeutics, Inc.(EWTX)500,000175,000-325,000$20.32M$7.11M0.80%-$13.21M
Grace Therapeutics Inc02,798,167+2,798,167$0$6.02M0.68%+$6.02M
Syndax Pharmaceuticals, Inc.(SNDX)0315,171+315,171$0$5.93M0.67%+$5.93M
Gossamer Bio Inc0426,989+426,989$0$5.06M0.57%+$5.06M
Adc Therapeutics SaSHS700,0004,070,819+3,370,819$749.0K$4.97M0.56%+$4.22M
Jasper Therapeutics Inc0280,808+280,808$0$4.89M0.55%+$4.89M
4d Molecular Therapeutics In334,437334,4370$4.45M$4.79M0.54%+$337.8K
Inhibrx Biosciences, Inc.(INBX)20,29145,500+25,209$1.92M$4.55M0.51%+$2.63M
Cabaletta Bio Inc3,863,8002,321,602-1,542,198$12.02M$4.46M0.50%-$7.56M
Trevi Therapeutics, Inc.(TRVI)310,000310,0000$5.78M$4.44M0.50%-$1.34M
Voyager Therapeutics Inc1,185,0001,630,000+445,000$4.15M$4.37M0.49%+$220.9K
Zentalis Pharmaceuticals Inc1,412,6561,412,6560$6.85M$3.91M0.44%-$2.94M
Ocular Therapeutix, Inc.(OCUL)600,000506,436-93,564$5.89M$3.88M0.44%-$2.01M
Relmada Therapeutics Inc935,0001,000,000+65,000$6.47M$3.77M0.42%-$2.70M
Annexon Inc1,714,451875,000-839,451$9.79M$3.70M0.42%-$6.09M
Opus Genetics Inc1,125,000750,000-375,000$4.62M$3.63M0.41%-$993.8K
Codexis Inc6,785,0002,590,000-4,195,000$15.33M$3.60M0.41%-$11.73M
Blossomhill Therapeutics Inc0175,000+175,000$0$3.26M0.37%+$3.26M
Lyell Immunopharma Inc344,025291,353-52,672$4.83M$2.85M0.32%-$1.98M
Rocket Pharmaceuticals Inc1,000,0001,000,0000$3.42M$2.63M0.30%-$790.0K
Biodesix Inc180,00087,000-93,000$4.06M$2.60M0.29%-$1.46M
Bridgebio Oncology Therapeut700,000630,000-70,000$5.33M$2.58M0.29%-$2.75M
Okyo Pharma LtdSHS NEW375,2041,620,000+1,244,796$562.8K$2.09M0.24%+$1.53M
Jade Biosciences Inc145,000140,463-4,537$3.22M$1.97M0.22%-$1.25M
Enanta Pharmaceuticals Inc125,000125,0000$1.82M$1.65M0.19%-$175.0K
Fortress Biotech Inc890,000720,000-170,000$2.72M$1.54M0.17%-$1.18M
Sanuwave Health Inc306,140306,1400$3.06M$1.44M0.16%-$1.62M
MBX Biosciences, Inc.(MBX)260,00020,000-240,000$14.35M$1.17M0.13%-$13.18M
Obsidian Therapeutics Inc075,755+75,755$0$1.04M0.12%+$1.04M
Journey Med Corp350,000125,000-225,000$2.48M$855.0K0.10%-$1.62M
Korro Bio Inc069,348+69,348$0$687.2K0.08%+$687.2K
Sionna Therapeutics Inc070,000+70,000$0$368.2K0.04%+$368.2K
Adagio Med Hldgs Inc18,44418,4440$13.4K$2.8K0.00%-$10.5K
Apogee Therapeutics Inc390,0000-390,000$51.76M$0—-$51.76M
Atea Pharmaceuticals, Inc.(AVIR)235,0000-235,000$1.09M$0—-$1.09M
CG Oncology, Inc.(CGON)17,7890-17,789$1.26M$0—-$1.26M
First Tracks Biotherapeutics65,0000-65,000$1.31M$0—-$1.31M
Hemab Therapeutics Hldgs Inc47,6520-47,652$1.75M$0—-$1.75M
Intellia Therapeutics, Inc.(NTLA)250,0000-250,000$4.23M$0—-$4.23M
Palatin Technologies, Inc.(PTN)20,5000-20,500$221.2K$0—-$221.2K
Pasithea Therapeutics Corp.(KTTA)2,050,0000-2,050,000$1.06M$0—-$1.06M
Phathom Pharmaceuticals, Inc.(PHAT)185,5890-185,589$2.01M$0—-$2.01M
Xoma Royalty Corporation338,3740-338,374$14.38M$0—-$14.38M
Page 1 of 1
Opaleye Management Inc. — 13F Holdings — Q3 2026 | TickerTrail